(2-苯乙基)丙胺 | 27906-91-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (2-苯乙基)丙胺
• 中文别名: (2-苯乙基)丙基胺
• 英文名称: N-propyl-2-phenylethylamine
• 英文别名: N-phenethylpropylamine；N-(2-Phenylethyl)propylamine；N-propylphenethylamine；phenethylpropan-1-amine；N-propylphenylethylamine；N-phenethylpropan-1-amine；N-propyl-N-phenethylamine；Phenaethyl-propyl-amin；phenethyl-propyl-amine；propylphenethylamine；N-propyl-(β-phenylethyl)amine；(2-Phenylethyl)propylamine；N-(2-phenylethyl)propan-1-amine
• CAS: 27906-91-8
• 化学式: C₁₁H₁₇N
• mdl: MFCD03724002
• 分子量: 163.263
• InChiKey: IIIRPZWDICEMGU-UHFFFAOYSA-N

物化性质

• 沸点：
  102 °C(Press: 16 Torr)
• 密度：
  0.904±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921199090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : (2-Phenylethyl)Propylamine
: CBR00107
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Eye irritation (Category 2), H319
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R36
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

---

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 163,26 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
(2-Phenylethyl)Propylamine
Eye Irrit. 2; H319 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
(2-Phenylethyl)Propylamine
Xi, R36 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

---

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
No data available
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available

---

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (2-苯乙基)丙胺 在 盐酸 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 作用下， 以 四氢呋喃 、 1,4-二氧六环 为溶剂， 生成 (4S,5R,6R)-5-Amino-4-azido-6-(phenethyl-propyl-carbamoyl)-5,6-dihydro-4H-pyran-2-carboxylic acid methyl ester
  参考文献：
  名称：

  Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides

  摘要：

  SAR investigations of the 4- and 5-positions of a series of 4-amino-4H-pyran-2-carboxylic acid 6-carboxamides are reported. Potent inhibitors of influenza A sialidase with marked selectivity over the influenza B enzyme were obtained when the basic 4-amino substituent was replaced by hydroxyl or even deleted. Modifications at the 5-position exhibited a tight steric requirement, with trifluoroacetamide being optimal. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00019-1
• 作为产物：
  描述：

  N-苯乙基丙酰胺 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 (2-苯乙基)丙胺
  参考文献：
  名称：

  Pd（OAc）2催化胺的羰基化

  摘要：

  无膦的催化体系[Pd（OAc）2 -Cu（OAc）2-空气]在沸腾的甲苯中，在CO气体（1个大气压）下引发了胺的底物特异性羰基化。通过伯胺的羰基化获得对称的N，N'-二烷基脲。N，N，N′-三烷基脲通过向上述反应容器中添加仲胺而选择性地形成。仲胺不产生四烷基脲。但是，在烷基链上带有苯基的二烷基胺，例如N-对单烷基化的苄胺或苯乙胺衍生物进行直接的芳族羰基化反应，得到五元或六元的苯并内酰胺。在羰基化反应中，发现Pd（II）与邻位钯的间位取代基之间的螯合效应或位阻以及羰基化之前形成的环钯的产物的环大小可产生良好的位点选择性并提高反应速率。相反，具有羟基的ω-芳基烷基胺的羰基化既不产生脲也没有苯并内酰胺，而是平稳地产生1，3-恶唑烷酮。在所用条件下，胺的盐酸盐也进行羰基化，得到相应的酰胺。该程序使得可以制备氨基酸酯的脲和实际收率的N-烷基氨基甲酸酯。

  DOI：

  10.1021/jo060612n

文献信息

• Chemoselective Reductive Amination of Aldehydes and Ketones by Dibutylchlorotin Hydride-HMPA Complex
  作者：Toshihiro Suwa、Erika Sugiyama、Ikuya Shibata、Akio Baba

  DOI：10.1055/s-2000-6273

  日期：——

  Reductive amination of various aldehydes and ketones has been performed effectively by pentacoordinate chloro-substituted tin hydride complex, Bu2SnClH-HMPA. The tin reagent worked particularly well for the case using weakly basic aromatic amines as starting substrates. Stoichiometric amounts of a substrate and a reducing agent were adequate for the reaction. The Sn-Cl bond in the complex plays an

  通过五配位氯取代的氢化锡络合物 Bu2SnClH-HMPA 可以有效地进行各种醛和酮的还原胺化。锡试剂在使用弱碱性芳香胺作为起始底物的情况下效果特别好。化学计量量的底物和还原剂足以进行反应。配合物中的 Sn-Cl 键在亚胺形成和随后的还原两个步骤中都起着重要作用。无论起始羰基和胺中的其他官能团如卤素、碳-碳双键和羟基如何，都可以实现羰基的高度化学选择性还原。
• Ruthenium-Catalyzed <i>N</i>-Alkylation of Amines with Alcohols under Mild Conditions Using the Borrowing Hydrogen Methodology
  作者：Arrey B. Enyong、Bahram Moasser

  DOI：10.1021/jo501273t

  日期：2014.8.15

  Using a simple amino amide ligand, ruthenium-catalyzed one-pot alkylation of primary and secondary amines with simple alcohols was carried out under a wide range of conditions. Using the alcohol as solvent, alkylation was achieved under mild conditions, even as low as room temperature. Reactions occurred with high conversion and selectivity in many cases. Reactions can also be carried out at high temperatures

  使用简单的氨基酰胺配体，在宽范围的条件下，用简单的醇进行钌催化的伯胺和仲胺的一锅烷基化。使用醇作为溶剂，即使在低至室温下也可以在温和的条件下实现烷基化。在许多情况下，以高转化率和选择性进行反应。使用化学计量的醇，反应也可以在有机溶剂中在高温下以高选择性进行。
• Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
  申请人：——

  公开号：US20030087948A1

  公开（公告）日：2003-05-08

  Compounds of the general formula I 1 wherein rings B, C, D and E may be present or not and, when present, are combined with A as A+C, A+E, A+B+C, A+B+D, A+B+E, A+C+E, A+B+C+D or A+B+C+D+E, rings B, C and E being aliphatic whereas ring D may be aliphatic or aromatic/hetero-aromatic, and wherein X is —(CH 2 ) m —, in which m is an integer 1-3, to form a ring E or, when E is absent, a group R 1 bound to the nitrogen atom, wherein R 1 is selected from the group consisting of a hydrogen atom, alkyl or haloalkyl groups of 1 to 3 carbon atoms, cycloalkyl(alkyl) groups of 3 to 5 carbon atoms (i.e. including cyclopropyl, cyclopropylmethyl, cyclobutyl and cyclobutylmethyl) and wherein Y is —(CH 2 ) n —, in which n is an integer 1-3, to form a ring C or when C is absent, a group R 2 bound to the nitrogen atom, wherein R 2 is selected from the group consisting of a hydrogen atom, alkyl or haloalkyl groups of 1 to 7 carbon atoms, cycloalkyl(alkyl) groups of 3 to 7 carbon atoms, alkenyl or alkylnyl groups of 3 to 6 carbon atoms, arylalkyl, heteroarylalkyl having 1 to 3 carbon atoms in the alkyl moiety, whilst the aryl/heteroaryl nucleus may be substituted, provided that when rings B, C, D and E are absent NR 1 R 2 is different from dimethylamino, N-methyl-N-ethylamino, N-methyl-N-propynyl-amino, N-methyl-N-propylamino and N-hydroxipropyl-N-methylamino, and salts thereof with pharmaceutically acceptable acids or bases are disclosed as well as the use of such compounds for the manufacturing of pharmaceutical compositions for the treatment of Parkinson's disease, psychoses, Huntington's disease, impotence, renal failure, heart failure or hypertension, such pharmaceutical compositions and methods of treating Parkinson's disease and schizophrenia.

  通式I的化合物 其中环B、C、D和E可能存在也可能不存在，当存在时，与A结合为A+C、A+E、A+B+C、A+B+D、A+B+E、A+C+E、A+B+C+D或A+B+C+D+E，环B、C和E为脂肪环，而环D可以是脂肪环或芳香/杂环，其中X为—(CH 2 ) m —，其中m为1-3的整数，形成环E或者当E不存在时，与氮原子结合的基团R 1 ，其中R 1 选自氢原子、1至3个碳原子的烷基或卤代烷基基团、3至5个碳原子的环烷基(烷基)基团（即包括环丙基、环丙基甲基、环丁基和环丁基甲基），Y为—(CH 2 ) n —，其中n为1-3的整数，形成环C或者当C不存在时，与氮原子结合的基团R 2 ，其中R 2 选自氢原子、1至7个碳原子的烷基或卤代烷基基团、3至7个碳原子的环烷基(烷基)基团、3至6个碳原子的烯基或烷基基团、芳基烷基、杂环芳基烷基，其中烷基部分含有1至3个碳原子，而芳基/杂环芳基核可能被取代，前提是当环B、C、D和E不存在时，NR 1 R 2 与二甲氨基、N-甲基-N-乙基氨基、N-甲基-N-丙炔基氨基、N-甲基-N-丙基氨基和N-羟基丙基-N-甲基氨基不同，并且还披露了这些化合物与药学上可接受的酸或碱的盐以及用于制造治疗帕金森病、精神病、亨廷顿病、阳痿、肾衰竭、心力衰竭或高血压的药物组合物的用途，以及治疗帕金森病和精神分裂症的药物组合物和方法。
• 3,3‘-Bis(trisarylsilyl)-Substituted Binaphtholate Rare Earth Metal Catalysts for Asymmetric Hydroamination
  作者：Denis V. Gribkov、Kai C. Hultzsch、Frank Hampel

  DOI：10.1021/ja058287t

  日期：2006.3.1

  Chiral 3,3'-bis(trisarylsilyl)-substituted binaphtholate rare earth metal complexes (R)-[LnBinol-SiAr3}(o-C6H4CH2NMe2)(Me2NCH2Ph)] (Ln = Sc, Lu, Y; Binol-SiAr3 = 3,3'-bis(trisarylsilyl)-2,2'-dihydroxy-1,1'-binaphthyl; Ar = Ph (2-Ln), 3,5-xylyl (3-Ln)) and (R)-[LaBinol-Si(3,5-xylyl)3}E(SiMe3)2}(THF)2] (E = CH (4a), N (4b)) are accessible via facile arene, alkane, and amine elimination. They are efficient

  手性 3,3'-双(三芳基甲硅烷基)-取代的联萘金属络合物 (R)-[LnBinol-SiAr3}(o-C6H4CH2NMe2)(Me2NCH2Ph)] (Ln = Sc, Lu, Y; Binol-SiAr3 = 3,3'-双(三芳基甲硅烷基)-2,2'-二羟基-1,1'-联萘；Ar = Ph (2-Ln)、3,5-二甲苯基 (3-Ln)) 和 (R)-[ LaBinol-Si(3,5-二甲苯基)3}E(SiMe3)2}(THF)2] (E = CH (4a), N (4b)) 可通过芳烃、烷烃和胺轻松消除. 它们是氨基烯烃不对称加氢胺化/环化的有效催化剂，使用 (R)-2- 在 25 摄氏度下为 2,2-二苯基-戊-4-烯胺 (5c) 提供高达 840 h(-1) 的 TOF Y。在 5c 与 (R)-2-Sc 的环化中实现了高达 95% ee 的对映选择性。反应显示出明显的零级
• Base-Catalyzed Anti-Markovnikov Hydroamination of Vinylarenes – Scope, Limitations and Computational Studies
  作者：Patricia Horrillo-Martínez、Kai C. Hultzsch、Adrià Gil、Vicenç Branchadell

  DOI：10.1002/ejoc.200700147

  日期：2007.7

  The hydroamination of vinylarenes with primary and secondary amines was studied with catalytic amounts as low as 2 mol-% of LiN(SiMe3)2/TMEDA. Reactions proceeded readily at 120 °C in the absence of solvent to give selective anti-Markovnikov addition. Slow addition was observed at 25 °C with either electron-deficient p-chlorostyrene or secondary cyclic amines such as pyrrolidine, piperidine, or morpholine

  使用低至 2 mol% 的 LiN(SiMe3)2/TMEDA 的催化量研究了乙烯基芳烃与伯胺和仲胺的加氢胺化。在没有溶剂的情况下，反应在 120 °C 下很容易进行，以提供选择性的抗马尔科夫尼科夫加成物。在 25 °C 下观察到使用缺电子对氯苯乙烯或仲环胺（如吡咯烷、哌啶或吗啉）缓慢添加。伯胺易于进行二次加氢胺化反应以形成叔胺副产物。单（加氢胺化）产物的选择性可以用两倍过量的胺来提高。与 LiN(SiMe3)2 相比，KN(SiMe3)2 显示出更高的催化活性，但选择性更低，导致不希望的 C-H 活化副产物。用密度泛函理论研究了锂催化加氢胺化的机理和TMEDA的影响。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)